Ohr Pharmaceutical intends to conduct public offering of common shares

Offering conducted via bookrunner Cowen and co-manager LifeSci Capital

By Devika Patel

Knoxville, Tenn., Feb. 5 – Ohr Pharmaceutical, Inc. said it plans a public sale of common stock with a 30-day, 15% greenshoe.

Cowen and Co., LLC is the bookrunner. LifeSci Capital, LLC is the co-manager.

Proceeds will be used for clinical trials, pre-clinical development and general corporate purposes.

Ohr is a biotechnology company based in New York.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.